hydroxyurea has been researched along with Carcinoma, Renal Cell in 2 studies
Carcinoma, Renal Cell: A heterogeneous group of sporadic or hereditary carcinoma derived from cells of the KIDNEYS. There are several subtypes including the clear cells, the papillary, the chromophobe, the collecting duct, the spindle cells (sarcomatoid), or mixed cell-type carcinoma.
| Excerpt | Relevance | Reference |
|---|---|---|
| "Mechanisms of chemoresistance in renal cell carcinoma include P-glycoprotein, overexpression of multidrug resistance-1 (mdr1) gene, and unstable chromosomal aberrations." | 1.31 | A pilot study of low dose hydroxyurea as a novel resistance modulator in metastatic renal cell cancer. ( Hao, D; Huan, SD; Segal, RJ; Stewart, DJ; Yau, JC, 2000) |
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 1 (50.00) | 18.2507 |
| 2000's | 1 (50.00) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Witte, RS | 1 |
| Hsieh, P | 1 |
| Elson, P | 1 |
| Oken, MM | 1 |
| Trump, DL | 1 |
| Hao, D | 1 |
| Huan, SD | 1 |
| Stewart, DJ | 1 |
| Segal, RJ | 1 |
| Yau, JC | 1 |
1 trial available for hydroxyurea and Carcinoma, Renal Cell
| Article | Year |
|---|---|
A phase II trial of amonafide, caracemide, and homoharringtonine in the treatment of patients with advanced renal cell cancer.
Topics: Adenine; Adult; Aged; Aged, 80 and over; Antineoplastic Combined Chemotherapy Protocols; Carcinoma, | 1996 |
1 other study available for hydroxyurea and Carcinoma, Renal Cell
| Article | Year |
|---|---|
A pilot study of low dose hydroxyurea as a novel resistance modulator in metastatic renal cell cancer.
Topics: Adult; Aged; Aged, 80 and over; Antineoplastic Agents; ATP Binding Cassette Transporter, Subfamily B | 2000 |